.png){kind=icon}
.png){kind=icon}
Return
Simultaneous Dual Type 2 Biologic Therapy Improves Sinonasal Outcomes in Selected Patients With Chronic Rhinosinusitis With Nasal Polyps
.png){kind=icon}
PRE
AI
F
J
E
A
F
P
M
U
S
L
DOI：10.1111/all.70452.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Due to the shared underlying pathophysiological mechanism, chronic rhinosinusitis with nasal polyps (CRSwNP) is frequently associated with comorbid systemic type 2 diseases. Rare, complex cases treated simultaneously with two biologics due to inadequate disease control have been reported. The aim of this study was to assess current use of dual biologic therapy in patients with CRSwNP.
Keywords:
biologic
eosinophilic granulomatous polyangiitis
monoclonal antibodies
nasal polyps
type-2 inflammation
Journal
A
IF:
12
Papers:
9.3K
Citations:
2.6W
Organization
Cited Papers